Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, P,R China.
Arthritis Res Ther. 2012 Jun 4;14(3):R133. doi: 10.1186/ar3866.
Rheumatoid arthritis (RA) is a chronic inflammatory disease leading to joint destruction and disability. Focal bone erosion is due to excess bone resorption of osteoclasts. Tumor necrosis factor receptor-associated factor 6 (TRAF6) is one of the critical mediators both in inflammatory signal pathway and differentiation and resorption activity of osteoclasts. Here we aimed to investigate TRAF6 expression in RA synovium and its correlation with histological synovitis severity and radiological joint destruction in RA.
Synovitis score was determined in needle biopsied synovium from 44 patients with active RA. Synovium from nine patients with osteoarthritis (OA) and seven with orthopedic arthropathies (Orth.A) were enrolled as "less inflamed" disease controls. Serial sections were stained immunohistochemically for TRAF6 as well as CD68 (macrophage), CD3 (T cell), CD20 (B cell), CD38 (plasmocyte), CD79a (B lineage cells from pre-B cell to plasmocyte stage), and CD34 (endothelial cell). Double immunofluorescence staining of TRAF6 and CD68 were tested. Densities of positive staining cells were determined and correlated with histological disease activity (synovitis score) and radiographic joint destruction (Sharp score).
TRAF6 expression was found in the intimal and subintimal area of RA synovium, with intense staining found in the endochylema and nucleus of intimal synoviocytes and subintimal inflammatory cells. Double immunofluorescence staining showed TRAF6 was expressed in most of the intimal cells and obviously expressed in CD68+ cells and some other CD68- cells in subintimal area. Synovial TRAF6 was significantly over-expressed in the RA group compared with the OA and Orth.A group (2.53 ± 0.94 vs. 0.72 ± 0.44 and 0.71 ± 0.49, P < 0.0001). Synovial TRAF6 expression in RA correlated significantly with synovitis score (r = 0.412, P = 0.006), as well as the inflammatory cell infiltration (r = 0.367, P = 0.014). Significant correlation was detected between synovial TRAF6 expression and intimal CD68+ cells, as well as the cell density of subintimal CD68+ cells, CD3+ cells, CD20+ cells, CD38+ cells, and CD79a+ cells (all P < 0.05).
Elevated synovial TRAF6 expression correlated with synovitis severity and CD68+ cell density in RA. It is, therefore, hypothesized that synovial TRAF6 is involved in the pathogenesis of synovial inflammation and osteoclast differentiation in RA.
类风湿关节炎(RA)是一种慢性炎症性疾病,可导致关节破坏和残疾。局灶性骨侵蚀是由于破骨细胞过度吸收骨所致。肿瘤坏死因子受体相关因子 6(TRAF6)是炎症信号通路以及破骨细胞分化和吸收活性中的关键介质之一。在此,我们旨在研究 RA 滑膜中 TRAF6 的表达及其与 RA 滑膜炎症严重程度和影像学关节破坏的相关性。
对 44 例活动性 RA 患者的滑膜活检进行滑膜炎症评分。纳入 9 例骨关节炎(OA)和 7 例矫形关节病(Orth.A)患者的滑膜作为“炎症较轻”的疾病对照。对 TRAF6 以及 CD68(巨噬细胞)、CD3(T 细胞)、CD20(B 细胞)、CD38(浆细胞)、CD79a(前 B 细胞至浆细胞阶段的 B 细胞谱系细胞)和 CD34(内皮细胞)进行免疫组织化学染色。测试 TRAF6 和 CD68 的双重免疫荧光染色。确定阳性染色细胞的密度,并与组织学疾病活动(滑膜炎症评分)和影像学关节破坏(Sharp 评分)相关。
TRAF6 表达于 RA 滑膜的内膜和内膜下区域,内膜滑膜细胞的胞质和核内有强烈染色,内膜下炎症细胞也有染色。双重免疫荧光染色显示,TRAF6 在大多数内膜细胞中表达,在内膜下区域的 CD68+细胞和一些其他 CD68-细胞中明显表达。与 OA 和 Orth.A 组相比,RA 组滑膜 TRAF6 表达明显升高(2.53±0.94 vs. 0.72±0.44 和 0.71±0.49,P<0.0001)。RA 患者滑膜 TRAF6 表达与滑膜炎评分显著相关(r=0.412,P=0.006),与炎症细胞浸润也显著相关(r=0.367,P=0.014)。滑膜 TRAF6 表达与内膜 CD68+细胞以及内膜下 CD68+细胞、CD3+细胞、CD20+细胞、CD38+细胞和 CD79a+细胞的细胞密度均呈显著正相关(均 P<0.05)。
升高的滑膜 TRAF6 表达与 RA 滑膜炎症严重程度和 CD68+细胞密度相关。因此,假设滑膜 TRAF6 参与了 RA 滑膜炎症和破骨细胞分化的发病机制。